Literature DB >> 27062949

Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis.

Claire Shuiqing Zhang1, Brian May1, Yuhong Yan2, Jason Jingjie Yu3, Danni Yao2, Suyueh Chang1, Anthony Lin Zhang1, Xinfeng Guo2, Chuanjian Lu4, Charlie Changli Xue5.   

Abstract

BACKGROUND: Psoriasis vulgaris is a modern medical term. In the classical Chinese medicine (CM) literature, this disorder could be classified under a diversity of terms. In order to explore how psoriasis vulgaris was conceptualized and managed throughout Chinese medical history, we undertook a systematic longitudinal analysis of descriptions in the classical CM literature of skin disorders consistent with psoriasis vulgaris.
METHODS: Candidate search terms were identified from 33 contemporary CM books as relevant to psoriasis vulgaris. Thirteen terms were used to search the Zhong Hua Yi Dian--'Encyclopaedia of Traditional Chinese Medicine', 4th edition, a digital collection of over 1000 medical books. Search results were entered in a spreadsheet, citations that were consistent with psoriasis vulgaris were identified based on: (i) a description of the features of psoriasis vulgaris and (ii) judgment by two clinicians regarding relevance to psoriasis vulgaris. Analysis focused on the use of terms by historical period (Chinese dynasty) and whether the terms were specific for psoriasis vulgaris
RESULTS: 608 citations dating from 363 to 1947AD were included. The two criteria for determining inclusion of citations were combined to select the pool of citations most relevant to psoriasis vulgaris. Sixty citations from eight search terms were found in this pool. Among the eight terms, Bai Bi, She Shi and Bi Feng consistently identified citations that were likely to be psoriasis. The earliest was from 1368AD (Ming dynasty). The remaining five terms yielded inconsistent results. Citations of disorders consistent with psoriasis vulgaris appear prior to 1368-1644AD (Ming dynasty), but the terms used were not specific for psoriasis.
CONCLUSIONS: Bai Bi, She Shi and Bi Feng are the terms most consistently used to refer to psoriasis vulgaris. They first appeared in 1368-1644AD (Ming dynasty) and Bai bi remains in use. Regarding the other terms, certain citations may have referred to psoriasis vulgaris, but in other cases these terms could be used for disorders whose descriptions were inconsistent with psoriasis. Crown
Copyright © 2015. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chinese medicine; Classical literature; Psoriasis; Scholastics; Terminology

Mesh:

Substances:

Year:  2016        PMID: 27062949     DOI: 10.1016/j.ctim.2015.12.014

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  4 in total

1.  PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice.

Authors:  Haiming Chen; Huazhen Liu; Chuanjian Lu; Maojie Wang; Xiong Li; Hui Zhao; Yuhong Yan; Wanling Yu; Ling Han; Zhenhua Dai
Journal:  Front Immunol       Date:  2018-01-08       Impact factor: 7.561

Review 2.  Effectiveness and safety of traditional Chinese medical bath therapy combined with ultraviolet irradiation in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Jingzhi Guan; Shaofei Yuan; Hanqimuge Wu; Risu Na; Xueqin Wu; Xin Wang; Shan Bao
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

3.  The Gene Expression Analysis of Peripheral Blood Monocytes From Psoriasis Vulgaris Patients With Different Traditional Chinese Medicine Syndromes.

Authors:  Yue Lu; Yao Qi; Li Li; Yuhong Yan; Jianan Wei; Danni Yao; Jingjing Wu; Hao Deng; Jingwen Deng; Shuyan Ye; Haiming Chen; Qubo Chen; Hengjun Gao; Ling Han; Chuanjian Lu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

4.  Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products.

Authors:  Xuan Xia; Brian H May; Anthony Lin Zhang; Xinfeng Guo; Chuanjian Lu; Charlie C Xue; Qingchun Huang
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-28       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.